Bobardt M, Ramirez CM, Baum MM, Ure D, et al. The combination of the NS5A and cyclophilin inhibitors results in an additive anti-HCV inhibition in humanized mice without development of resistance. PLoS One 2021;16:e0251934.
PMID: 34014993